文献速递口腔修复与种植

骨替代材料在种植体周围炎手术治疗中的应用——随机对照试验的3年结果

Bone Substitute Material in the Surgical Therapy of Peri-Implantitis-3-Year Outcomes of a Randomized Controlled Trial.
PubMed 文献 · Clin Oral Implants Res · 2024-12-20

多中心随机对照试验纳入120名受试者(127枚种植体),比较翻瓣手术联合骨替代材料与单纯翻瓣手术治疗种植体周围炎的3年效果。两组临床参数均明显改善,但使用骨替代材料并未较单纯翻瓣手术显示出明确优势;复合主要结局仅在14%的种植体达成。

要点

  • 3年随访时,骨替代材料联合翻瓣手术较单纯翻瓣手术未显示明确额外获益。
  • 两组剩余种植体的探诊深度降低3.2-3.5 mm,边缘骨水平增加1.1-1.3 mm。
  • 复合主要结局仅在14%的种植体达成,定义疾病缓解的复合结局在39%的种植体达成。

核心结论

  • 3年随访时,在种植体周围炎手术治疗中使用骨替代材料并未较单纯翻瓣手术带来明确获益。

研究设计与样本

  • 多中心随机对照试验,共纳入120名受试者(127枚种植体),随访3年。
  • 受试者随机分为对照组(翻瓣手术)和试验组(翻瓣手术联合骨替代材料)。
  • 评估临床、影像学和患者报告结局,主要结局为复合指标:探诊深度≤5 mm、探诊无出血和溢脓、软组织退缩≤1 mm、种植体未再手术且未脱落。

主要发现

  • 14枚种植体(11%)脱落,3枚种植体(2.4%)接受了第二次手术干预。
  • 两组剩余种植体在3年随访时临床参数均明显改善:探诊深度降低3.2-3.5 mm,边缘骨水平增加1.1-1.3 mm。
  • 复合主要结局仅在14%的种植体达成;定义疾病缓解的复合结局(允许一个出血位点且不考虑退缩)在39%的种植体达成。
  • 患者报告结局总体良好。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the potential mid-term benefit of the use of a bone substitute material in the reconstructive surgical treatment of peri-implantitis. METHODS: A total of 120 subjects (127 implants) affected by peri-implantitis were followed over 3 years in a multicenter randomized clinical trial. Participants had been randomized to either control (access flap surgery) or test group (access flap surgery and bone substitute material). Clinical, radiographic, and patient-reported outcomes were assessed. The primary outcome was a composite measure including probing pocket depth ≤ 5 mm, absence of bleeding and suppuration on probing, soft tissue recession ≤ 1 mm, and implant neither reoperated nor lost. In an additional outcome (disease resolution), we allowed for one bleeding site and did not consider recession. RESULTS: While 14 implants (11%) were lost and a second surgical intervention had been performed at 3 implants (2.4%), pronounced improvements of clinical parameters were noted at remaining implants in both treatment groups at the 3-year follow-up. This was illustrated by a 3.2-3.5 mm reduction in probing pocket depth and a marginal bone level gain of 1.1-1.3 mm. The primary composite outcome, however, was only achieved at 14% of implants. The second composite outcome defining disease resolution was accomplished at 39% of implants. Patient-reported outcomes were generally favorable. CONCLUSION: At 3 years, the use of a bone substitute material in the surgical therapy of peri-implantitis did not result in a clear benefit over access flap surgery alone. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT0307706.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Alibegovic L, Trullenque-Eriksson A, Ortiz-Vigón A, et al. Bone Substitute Material in the Surgical Therapy of Peri-Implantitis-3-Year Outcomes of a Randomized Controlled Trial. Clin Oral Implants Res. 2024. PMID: 39704200. doi:10.1111/clr.14393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。